Trials / Completed
CompletedNCT03233997
CSD170302: Study to Assess Nicotine Uptake in Smokers From Electronic Cigarettes
CSD170302: An Unblinded, Parallel, Randomized Study to Assess Nicotine Uptake in Smokers From Electronic Cigarettes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 121 (actual)
- Sponsor
- RAI Services Company · Industry
- Sex
- All
- Age
- 21 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
To determine the rate and amount of nicotine uptake with 10-minute ad libitum use of four different marketed electronic cigarettes. Furthermore, to measure overall product liking by subjects to assess potential willingness to seek out the Electronic Cigarette (EC) again in the future.
Detailed description
This will be a single-center, randomized, open-label, parallel study during which up to 140 healthy adult subjects, consisting of 35 subjects per marketed EC product, will be enrolled. Subjects will be evaluated for plasma nicotine uptake, as well as overall product liking. The study will involve the use of four (4) marketed EC products in tobacco consumers who are exclusive smokers (i.e., naïve EC users) or dual users of cigarettes and ECs (i.e., intermittent EC users).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | FT21018 | An electronic cigarette |
| OTHER | FT21033 | An electronic cigarette |
| OTHER | FT21034 | An electronic cigarette |
| OTHER | FT21035 | An electronic cigarette |
Timeline
- Start date
- 2017-07-18
- Primary completion
- 2017-09-30
- Completion
- 2017-09-30
- First posted
- 2017-07-31
- Last updated
- 2017-10-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03233997. Inclusion in this directory is not an endorsement.